Search
News
Tejon Ranch Q2 2026 Earnings: Land Sale Helps Restore Profitability
Tejon Ranch’s Q2 2026 revenue increased about 72% year over year to $14.3 million, while diluted EPS improved to $0.10 from a $0.06 loss. Net income attributable to common stockholders reached $2.6 million, and adjusted EBITDA rose 46% to $8.4 million. The quarter benefited from a $6.9 million land sale tied to the Dedeaux Properties joint venture, lower corporate expenses, and growth in multifamily, mineral resources, and ranch operations. Investors should monitor land-sale timing, Terra Vista leasing, development spending, and farming yield uncertainty after unfavorable bloom-period rainfall.
TradingKey
Thu, Aug 6
Aemetis Q2 2026 earnings: Tax credits restore operating profit
Aemetis reported Q2 2026 revenue of $62.7 million, up 20% year over year, while diluted loss per share narrowed to $0.13 from $0.41. Gross profit reached $13.5 million and operating income turned positive at $5.8 million, helped by $8.6 million of Section 45Z tax-credit revenue, lower delivered corn costs, and higher Dairy RNG production. Adjusted EBITDA improved to $9.7 million, but $15.2 million of total interest expense left the company with a $9.4 million net loss. Cash ended the quarter at $1.0 million, keeping financing and liquidity central to the outlook.
TradingKey
Thu, Aug 6
Globalstar Q2 2026 earnings: Higher costs drive an operating loss
Globalstar (GSAT) reported Q2 2026 revenue of $64.8 million, down about 4% year over year, and diluted EPS of -$0.23 versus $0.13. Adjusted EBITDA declined 27% to $26.0 million as higher network, XCOM development and transaction-related costs outweighed Commercial IoT growth and higher equipment sales. The prior-year quarter also included $6.6 million of out-of-period wholesale capacity revenue. For the first half, adjusted free cash flow fell to $43.5 million while capital expenditures reached $208.3 million amid continued satellite and ground-network investment.
TradingKey
Thu, Aug 6
Establishment Labs Q2 2026 earnings: U.S. growth lifts gross margin
Establishment Labs (NASDAQ: ESTA) reported Q2 2026 revenue of $67.5 million, up 31.7% year over year, while diluted net loss per share narrowed to $0.39 from $0.57. Gross margin increased to 70.6% from 68.8% as higher-margin U.S. and minimally invasive sales improved the mix, and adjusted EBITDA turned positive at $3.7 million. Motiva USA revenue reached $24.7 million, and the company raised full-year revenue guidance to $269 million-$271 million. GAAP losses, negative first-half operating cash flow, and debt remain important areas to monitor.
TradingKey
Thu, Aug 6
Hertz Q2 2026 Earnings: Pricing Drives 10% Revenue Growth
Hertz Q2 2026 revenue rose 10% year over year to $2.396 billion as RPD increased 9% despite a 1% smaller average fleet and essentially flat transaction days. GAAP net income reached $64 million, or $0.05 per diluted share, while adjusted Corporate EBITDA improved by $63 million to $81 million. Pricing outpaced daily operating-cost growth, but recalls affected nearly 15,000 vehicles and reduced adjusted EBITDA by about $30 million. Hertz expects full-year RPU above $1,500 and net depreciation per unit of $300 or less.
TradingKey
Thu, Aug 6
Marcus & Millichap Q2 2026 Earnings: Revenue Growth Restores Profitability
Marcus & Millichap’s preliminary Q2 2026 earnings showed revenue rising 17.8% year over year to $202.9 million, while diluted EPS improved to $0.10 from a $0.28 loss. Net income reached $3.9 million versus an $11.0 million loss, and adjusted EBITDA increased to $12.1 million from $1.5 million. Brokerage commissions and financing fees both advanced, led by faster growth in larger transactions, although a higher commission mix lifted cost of services to 62.4% of revenue. Management expects rate, inflation and bid-ask spread pressures to persist through 2026.
TradingKey
Thu, Aug 6
CION Q2 2026 Earnings: Unrealized Gains Lift NAV and EPS
CION Investment Corporation’s Q2 2026 total investment income fell 4.7% year over year to $49.8 million, while earnings per share rose to $0.62 from $0.52. Net investment income declined to $14.2 million, or $0.29 per share, but $34.8 million of unrealized gains lifted quarterly earnings and helped NAV per share increase 3.5% sequentially to $13.57. The funded portfolio contracted by $90 million, non-accrual exposure improved, and net debt-to-equity declined to 1.52x as CION continued deleveraging and expanded its authorized repurchase program to $130 million.
TradingKey
Thu, Aug 6
USA TODAY Co. Q2 2026 Earnings: Cost Cuts Support Profit Despite Lower Revenue
USA TODAY Co. (NYSE: TDAY) reported Q2 2026 revenue of $536.3 million, down 8.3% year over year, while diluted EPS fell to $0.06 from $0.52. The EPS comparison was distorted by an $87.5 million tax benefit in the prior-year quarter; pretax income improved to $14.5 million from a $9.1 million loss. Free cash flow rose approximately 11% to $19.6 million, and management reiterated its 2026 outlook as digital subscriptions grew but total digital and print revenue remained lower.
TradingKey
Thu, Aug 6
Ralph Lauren Fiscal Q1 2027 Earnings: Revenue Rises 14% as Margins Expand
Ralph Lauren’s fiscal Q1 2027 revenue rose 14% to $2.0 billion, while GAAP diluted EPS increased 22% to $4.28. Adjusted operating margin expanded 170 basis points to 18.7%, supported by 15% growth in average unit retail, full-price demand, and favorable channel and geographic mix despite tariff and product-cost pressure. Asia led the regions with 24% reported revenue growth, while North America increased 13%. The company raised its full-year constant-currency revenue outlook to 5%-6% and now expects 60-80 basis points of constant-currency operating-margin expansion.
TradingKey
Thu, Aug 6
Insight Enterprises Q2 2026 Earnings: AI-Led Growth Expands Margins
Insight Enterprises’ Q2 2026 net sales rose 15% year over year to $2.40 billion, while GAAP diluted EPS climbed 76% to $2.57. Gross profit increased 18% to $521.6 million and gross margin widened 60 basis points to 21.7%, supported by AI-related demand across cloud, infrastructure, and services. Adjusted diluted EPS advanced 44% to $3.86, although operating activities used $12.2 million of cash. North America drove operating profit growth, while EMEA remained a pressure point. The company also raised its full-year guidance.
TradingKey
Thu, Aug 6
Delcath Q2 2026 Earnings: Revenue Rises While Clinical Spending Pressures EBITDA
Delcath Systems’ Q2 2026 revenue rose about 21% year over year to $29.1 million, led by $27.1 million from HEPZATO KIT, while diluted EPS remained $0.07. Gross margin improved to 90% from 86%, but adjusted EBITDA declined to $7.6 million as R&D and SG&A expenses increased. Quarterly operating cash flow was $5.7 million, and cash and investments ended June at $95.9 million with no debt. Delcath raised full-year 2026 revenue guidance to $104 million-$108 million and expects HEPZATO volume growth of at least 28%.
TradingKey
Thu, Aug 6
BlackRock TCP Capital Q2 2026 Earnings: Portfolio Sale Resets Leverage
BlackRock TCP Capital’s Q2 2026 earnings showed total investment income of approximately $40.0 million and GAAP net investment income of $18.1 million, or $0.22 per diluted share, versus $0.32 a year earlier. NAV ended the quarter at $6.58 per share. After quarter-end, TCPC agreed to sell 95% of a vehicle holding roughly $523 million of investments, a transaction expected to cut pro forma net leverage to about 0.4x but reduce NAV by approximately 10.4%, sharpening the trade-off between financial flexibility and book value.
TradingKey
Thu, Aug 6
Edgewise Q2 2026 Results: Higher R&D Spending Widens the Net Loss
Edgewise Therapeutics’ Q2 2026 results showed a net loss of $57.3 million, or $0.53 per share, versus $36.1 million and $0.34 a year earlier. R&D expense rose about 42% to $47.5 million as clinical development activity increased. Cash, cash equivalents and marketable securities totaled $460.7 million at June 30, excluding the $1.55 billion upfront proceeds received in July from Servier. The transaction shifts Edgewise to a cardiovascular-focused pipeline while providing funding for planned EDG-7500 and EDG-15400 trials.
TradingKey
Thu, Aug 6
Chegg Q2 2026 Earnings: Cost Cuts Support Cash Flow as Revenue Falls 51%
Chegg’s Q2 2026 revenue fell 51% year over year to $51.8 million, while GAAP net loss was $3.0 million. Cost reductions helped produce $9.1 million of adjusted EBITDA, a 17% margin, and $6.4 million of free cash flow despite restructuring payments. Chegg Skilling revenue rose 2% to $17.5 million but did not offset weakness elsewhere. For Q3, management guided to $43 million-$44 million of revenue, 48%-49% gross margin, and $1 million-$2 million of adjusted EBITDA as Chegg begins launching its employability platform.
TradingKey
Thu, Aug 6
Whitehawk Q2 2026 earnings: Cash runway extends into the second half of 2028
Whitehawk Therapeutics’ Q2 2026 results showed no revenue and a net loss of $16.6 million, narrower than $52.6 million a year earlier, as Q2 2025 included a $38.0 million upfront license fee. Diluted loss per share improved to $0.20 from $0.76. Cash, cash equivalents and short-term investments reached $190.0 million at June 30 after an $87.5 million private placement, supporting an expected runway into the second half of 2028. Whitehawk continued enrolling HWK-007 and HWK-016 and plans to start the HWK-206 Phase 1 study in Q3 2026.
TradingKey
Thu, Aug 6
FOX Fiscal Q4 2026 Earnings: World Cup Drives 28% Revenue Growth
Fox Corporation’s fiscal Q4 2026 revenue rose 28% to $4.21 billion, driven by the FIFA Men’s World Cup and continued Tubi-led digital advertising growth. Adjusted EBITDA increased 27% to $1.20 billion, and adjusted EPS climbed to $1.79 from $1.27. However, GAAP net income slipped to $696 million from $719 million as the prior-year quarter included a larger non-operating benefit. Television produced most of the profit growth, while Cable Network Programming EBITDA declined despite higher revenue. Full-year operating cash flow also fell as working capital absorbed cash.TradingKey
Thu, Aug 6
Sempra Q2 2026 Earnings: Profit Rises Despite Flat Revenue
Sempra’s Q2 2026 revenue was $2.997 billion, nearly unchanged from $3.000 billion a year earlier, while GAAP diluted EPS rose to $1.21 from $0.71 and adjusted EPS increased to $1.16 from $0.89. Higher equity earnings, lower tax expense, and gains across California, Texas, and Infrastructure supported profit growth, although interest expense increased. First-half operating cash flow reached $3.117 billion against more than $6 billion of capital spending. Sempra affirmed 2026 adjusted EPS guidance of $4.80 to $5.30 and its 7% to 9% long-term EPS growth target.
TradingKey
Thu, Aug 6
Novavax Q2 2026 earnings: Revenue falls as prior-year payments roll off
Novavax’s Q2 2026 revenue fell 76% year over year to $56.7 million as prior-year milestone and amendment revenue rolled off, while diluted EPS shifted to a $0.32 loss from $0.62 profit. Product sales rose 76% to $18.9 million, but licensing, royalties and other revenue dropped 83% to $37.8 million. The company raised its full-year adjusted revenue framework to $235 million-$275 million and reduced GAAP combined R&D and SG&A guidance to $370 million-$410 million, while leaving the non-GAAP expense range unchanged. Cash and related holdings ended June at $723.9 million.
TradingKey
Thu, Aug 6
Koppers Q2 2026 Earnings: Sales Rise as Margins Weaken
Koppers’ Q2 2026 earnings showed a 3.0% increase in net sales to $520.1 million, but adjusted EBITDA fell 7.9% to $71.0 million as raw-material, freight, and legal costs, unfavorable RUPS pricing, and divestitures pressured profitability. A $215.8 million impairment, restructuring, and plant-closure charge drove a GAAP net loss of $147.5 million and diluted EPS of negative $7.71. Performance Chemicals improved while RUPS and Carbon Materials and Chemicals weakened, prompting Koppers to narrow adjusted EBITDA and adjusted EPS guidance while maintaining its cash-flow outlook.
TradingKey
Thu, Aug 6
MACOM Fiscal Q3 2026 Earnings: Revenue Growth Expanded Operating Margins
MACOM Technology Solutions (MTSI) reported fiscal third-quarter 2026 revenue of $342.2 million, up 35.8% year over year, while GAAP diluted EPS rose to $1.28 from $0.48. GAAP operating margin expanded to 22.5% from 14.9%, reflecting higher gross margin and operating leverage, though a $41.5 million investment fair-value gain materially lifted net income. For fiscal Q4, MACOM guided to $415 million-$425 million in revenue, a 60.0%-61.0% adjusted gross margin, and adjusted EPS of $1.97-$2.03, requiring a sizable sequential revenue step-up.
TradingKey
Thu, Aug 6
Featured Tools
Top News
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
The Week Ahead: Fed Minutes, Walmart, Target and Home Depot Earnings to Test US Consumer Resilience
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
SK Hynix Stock Forecast: Can HBM4 Demand Drive a Breakout Toward $194?
Broadcom Stock Price Forecast: Can It Break $500 Before Earnings Amid Strong Custom AI Chip Demand?
